Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
28.60 SEK | -0.69% | -0.69% | -20.11% |
08-29 | First Patient Dosed in Guard Therapeutics' Phase 2B Study POINTER | CI |
08-27 | Guard Therapeutics Plans New SEK80 Million Rights Issue to Fund Kidney Drug Study | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GUARD THERAPEUTICS INTERNATIONAL AB | Other Biotechnology & Medical Research | -0.69% | -0.69% | -20.11% | +282.61% | -63.80% | 33.82M |
- Stock Market
- Equities
- GUARD Stock
- Charts Guard Therapeutics International AB
- Relative Strength Chart
MarketScreener is also available in this country: United States.
Switch edition